<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/694"/><api:result><api:object category="publication" id="694" last-affected-when="2024-03-18T02:08:34.92+00:00" last-modified-when="2024-03-18T02:08:34.92+00:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/694" created-when="2010-05-17T13:46:27.227+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>1999-12-15</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="1491746" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1016/S0014-2999(99)00788-8" last-modified-when="2022-09-10T12:07:27.763+01:00"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="2540" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2540"/></api:links><api:last-name>Elliott</api:last-name><api:initials>J</api:initials><api:first-names>Jackie</api:first-names><api:separate-first-names><api:first-name>Jackie</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Reynolds</api:last-name><api:initials>GP</api:initials><api:first-names>Gavin P</api:first-names><api:separate-first-names><api:first-name>Gavin</api:first-name><api:first-name>P</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0014-2999(99)00788-8</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0014-2999(99)00788-8"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0014-2999(99)00788-8"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0014-2999</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/968259"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2-3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>European Journal of Pharmacology</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>313</api:begin-page><api:end-page>315</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>12</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Elsevier BV</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1016/s0014-2999(99)00788-8</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>30</api:day><api:month>4</api:month><api:year>2019</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Agonist-stimulated GTPγ[35S] binding to 5-HT1A receptors in human post-mortem brain</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>386</api:text></api:field></api:native></api:record><api:record format="native" id="94941" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0033233167" last-modified-when="2021-06-23T15:05:14.98+01:00"><api:citation-count>27</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>In this study, we have demonstrated that the technique of agonist- stimulated guanosine-5'-O-(3-[35S]thio)-triphosphate (GTPγ[35S]) binding can be successfully used to study the functional activity of the human 5- HT(1A) receptor in post-mortem tissue. Full agonist and antagonist actions of ligands specific for this site have been shown. Utilising 4-(2'-methoxy- phenyl)-1-[2'-(n-2''-pyridinyl)-p-fluorobenzamido]-ethyl-piperazine ([3H]MPPF), the affinity of several antipsychotics for the 5-HT(1A) receptor was determined; clozapine and quetiapine were found to have K(i) values at this receptor that, relative to their dopamine D2 receptor affinities, indicated at least partial receptor occupancy at clinical doses. The agonist/antagonist activity of these two antipsychotics was studied using GTPγ[35S] binding. Both compounds show partial agonism, and in addition, clozapine exhibited a larger degree of antagonism against 5-HT-stimulated binding than did quetiapine.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="2540" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2540"/></api:links><api:last-name>Elliott</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">57198644295</api:identifier></api:identifiers></api:person><api:person><api:last-name>Reynolds</api:last-name><api:initials>GP</api:initials><api:first-names>GP</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>P</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7201487920</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/S0014-2999(99)00788-8</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/S0014-2999(99)00788-8"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/S0014-2999(99)00788-8"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10618484</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0014-2999</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/968259"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2-3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>European Journal of Pharmacology</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>313</api:begin-page><api:end-page>315</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>15</api:day><api:month>12</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Agonist-stimulated GTPγ[&lt;sup&gt;35&lt;/sup&gt;S] binding to 5-HT(1A) receptors in human post-mortem brain</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>386</api:text></api:field></api:native></api:record><api:record format="native" id="694" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10618484" last-modified-when="2020-04-29T00:35:09.283+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>In this study, we have demonstrated that the technique of agonist-stimulated guanosine-5'-O-(3-[35S]thio)-triphosphate (GTPgamma[35S]) binding can be successfully used to study the functional activity of the human 5-HT(1A) receptor in post-mortem tissue. Full agonist and antagonist actions of ligands specific for this site have been shown. Utilising 4-(2'-methoxy-phenyl)-1-[2'-(n-2''-pyridinyl)-p-fluorobenzamido]- ethyl-piperazine ([3H]MPPF), the affinity of several antipsychotics for the 5-HT(1A) receptor was determined; clozapine and quetiapine were found to have K(i) values at this receptor that, relative to their dopamine D(2) receptor affinities, indicated at least partial receptor occupancy at clinical doses. The agonist/antagonist activity of these two antipsychotics was studied using GTPgamma[35S] binding. Both compounds show partial agonism, and in addition, clozapine exhibited a larger degree of antagonism against 5-HT-stimulated binding than did quetiapine.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="2540" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2540"/></api:links><api:last-name>Elliott</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Department of Biomedical Science, University of Sheffield, Western Bank, Sheffield, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Reynolds</api:last-name><api:initials>GP</api:initials><api:first-names>GP</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>P</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10618484</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0014-2999(99)00788-8</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0014-2999(99)00788-8"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0014-2999(99)00788-8"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0014-2999</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/968259"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2-3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Eur J Pharmacol</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Aminopyridines</api:keyword><api:keyword scheme="mesh">Brain</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Guanosine 5'-O-(3-Thiotriphosphate)</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">Piperazines</api:keyword><api:keyword scheme="mesh">Postmortem Changes</api:keyword><api:keyword scheme="mesh">Radioligand Assay</api:keyword><api:keyword scheme="mesh">Receptors, Serotonin</api:keyword><api:keyword scheme="mesh">Receptors, Serotonin, 5-HT1</api:keyword><api:keyword scheme="mesh">Serotonin Antagonists</api:keyword><api:keyword scheme="mesh">Sulfur Radioisotopes</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>Netherlands</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>313</api:begin-page><api:end-page>315</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>S0014299999007888</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>15</api:day><api:month>12</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>29</api:day><api:month>2</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Agonist-stimulated GTPgamma[35S] binding to 5-HT(1A) receptors in human post-mortem brain.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>386</api:text></api:field></api:native></api:record><api:record format="native" id="881990" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10618484" last-modified-when="2020-10-13T17:27:04.31+01:00"><api:citation-count>15</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>In this study, we have demonstrated that the technique of agonist-stimulated guanosine-5'-O-(3-[35S]thio)-triphosphate (GTPgamma[35S]) binding can be successfully used to study the functional activity of the human 5-HT(1A) receptor in post-mortem tissue. Full agonist and antagonist actions of ligands specific for this site have been shown. Utilising 4-(2'-methoxy-phenyl)-1-[2'-(n-2''-pyridinyl)-p-fluorobenzamido]- ethyl-piperazine ([3H]MPPF), the affinity of several antipsychotics for the 5-HT(1A) receptor was determined; clozapine and quetiapine were found to have K(i) values at this receptor that, relative to their dopamine D(2) receptor affinities, indicated at least partial receptor occupancy at clinical doses. The agonist/antagonist activity of these two antipsychotics was studied using GTPgamma[35S] binding. Both compounds show partial agonism, and in addition, clozapine exhibited a larger degree of antagonism against 5-HT-stimulated binding than did quetiapine.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Department of Biomedical Science, University of Sheffield, Western Bank, Sheffield, UK.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="2540" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2540"/></api:links><api:last-name>Elliott</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Reynolds</api:last-name><api:initials>GP</api:initials><api:first-names>GP</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>P</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0001-9026-7726</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0014-2999(99)00788-8</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0014-2999(99)00788-8"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0014-2999(99)00788-8"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1879-0712</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/968259"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10618484</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0014-2999</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/968259"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2-3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>European journal of pharmacology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Brain</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Postmortem Changes</api:keyword><api:keyword scheme="mesh">Sulfur Radioisotopes</api:keyword><api:keyword scheme="mesh">Aminopyridines</api:keyword><api:keyword scheme="mesh">Piperazines</api:keyword><api:keyword scheme="mesh">Receptors, Serotonin</api:keyword><api:keyword scheme="mesh">Receptors, Serotonin, 5-HT1</api:keyword><api:keyword scheme="mesh">Guanosine 5'-O-(3-Thiotriphosphate)</api:keyword><api:keyword scheme="mesh">Serotonin Antagonists</api:keyword><api:keyword scheme="mesh">Radioligand Assay</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Male</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>313</api:begin-page><api:end-page>315</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>12</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>5</api:day><api:month>1</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Agonist-stimulated GTPgamma[35S] binding to 5-HT(1A) receptors in human post-mortem brain.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>386</api:text></api:field></api:native></api:record><api:record format="native" id="2506554" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1026380026" last-modified-when="2024-03-18T02:08:34.923+00:00"><api:citation-count>22</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="2540" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2540"/></api:links><api:last-name>Elliott</api:last-name><api:initials>J</api:initials><api:first-names>Jackie</api:first-names><api:separate-first-names><api:first-name>Jackie</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Reynolds</api:last-name><api:initials>GP</api:initials><api:first-names>Gavin P</api:first-names><api:separate-first-names><api:first-name>Gavin</api:first-name><api:first-name>P</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Sheffield</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01067671123.21</api:identifier></api:identifiers><api:author-types><api:author-type>corresponding</api:author-type></api:author-types></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0014-2999(99)00788-8</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0014-2999(99)00788-8"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0014-2999(99)00788-8"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10618484</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0014-2999</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/968259"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2-3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>European Journal of Pharmacology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">3214 Pharmacology and Pharmaceutical Sciences</api:keyword><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="rcdc">Neurosciences</api:keyword><api:keyword scheme="rcdc">Brain Disorders</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Aminopyridines</api:keyword><api:keyword scheme="mesh">Brain</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Guanosine 5'-O-(3-Thiotriphosphate)</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">Piperazines</api:keyword><api:keyword scheme="mesh">Postmortem Changes</api:keyword><api:keyword scheme="mesh">Radioligand Assay</api:keyword><api:keyword scheme="mesh">Receptors, Serotonin</api:keyword><api:keyword scheme="mesh">Receptors, Serotonin, 5-HT1</api:keyword><api:keyword scheme="mesh">Serotonin Antagonists</api:keyword><api:keyword scheme="mesh">Sulfur Radioisotopes</api:keyword></api:keywords></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Closed Access</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>313</api:begin-page><api:end-page>315</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>12</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Elsevier</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>0.8</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Agonist-stimulated GTPγ[35S] binding to 5-HT1A receptors in human post-mortem brain</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>386</api:text></api:field></api:native></api:record><api:record format="native" id="241034" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000084502700023" last-modified-when="2024-03-14T05:40:48.37+00:00"><api:citation-count>27</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="2540" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2540"/></api:links><api:last-name>Elliott</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="researcherid">B-1268-2011</api:identifier></api:identifiers></api:person><api:person><api:last-name>Reynolds</api:last-name><api:initials>GP</api:initials><api:first-names>GP</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>P</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="researcherid">AAM-9985-2020</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000084502700023&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/S0014-2999(99)00788-8</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/S0014-2999(99)00788-8"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/S0014-2999(99)00788-8"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">269XL</api:identifier><api:identifier scheme="pubmed">10618484</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0014-2999</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/968259"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2-3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>EUROPEAN JOURNAL OF PHARMACOLOGY</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>5-HT1A receptor</api:keyword><api:keyword>GTP gamma[S-35]</api:keyword><api:keyword>brain, human</api:keyword><api:keyword>antipsychotic drug</api:keyword><api:keyword>clozapine</api:keyword><api:keyword>quetiapine</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>313</api:begin-page><api:end-page>315</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Agonist-stimulated GTPγ[&lt;SUP&gt;35&lt;/SUP&gt;S] binding to 5-HT&lt;sub&gt;1A&lt;/sub&gt; receptors in human post-mortem brain</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>386</api:text></api:field></api:native></api:record><api:record format="native" id="23952" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000084502700023" last-modified-when="2014-07-25T11:05:02.97+01:00"><api:citation-count>20</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="2540" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/2540"/></api:links><api:last-name>Elliott</api:last-name><api:initials>J</api:initials><api:first-names>J</api:first-names><api:separate-first-names><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Reynolds</api:last-name><api:initials>GP</api:initials><api:first-names>GP</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>P</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0014-2999</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/968259"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2-3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>EUR J PHARMACOL</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>5-HT1A receptor</api:keyword><api:keyword>GTP gamma[S-35]</api:keyword><api:keyword>brain, human</api:keyword><api:keyword>antipsychotic drug</api:keyword><api:keyword>clozapine</api:keyword><api:keyword>quetiapine</api:keyword><api:keyword>GAMMA-S BINDING</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>313</api:begin-page><api:end-page>315</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>15</api:day><api:month>12</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Agonist-stimulated GTP gamma[S-35] binding to 5-HT1A receptors in human post-mortem brain</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>386</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Aminopyridines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Brain</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Guanosine 5'-O-(3-Thiotriphosphate)</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Piperazines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Postmortem Changes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Radioligand Assay</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Receptors, Serotonin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Receptors, Serotonin, 5-HT1</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Serotonin Antagonists</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Sulfur Radioisotopes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Brain</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Postmortem Changes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Sulfur Radioisotopes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Aminopyridines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Piperazines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Receptors, Serotonin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Receptors, Serotonin, 5-HT1</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Guanosine 5'-O-(3-Thiotriphosphate)</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Serotonin Antagonists</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Radioligand Assay</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Male</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3214 Pharmacology and Pharmaceutical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Neurosciences</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Brain Disorders</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Aminopyridines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Brain</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Guanosine 5'-O-(3-Thiotriphosphate)</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Piperazines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Postmortem Changes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Radioligand Assay</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Receptors, Serotonin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Receptors, Serotonin, 5-HT1</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Serotonin Antagonists</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Sulfur Radioisotopes</api:keyword><api:keyword origin="record-data" source="wos-lite">5-HT1A receptor</api:keyword><api:keyword origin="record-data" source="wos-lite">GTP gamma[S-35]</api:keyword><api:keyword origin="record-data" source="wos-lite">brain, human</api:keyword><api:keyword origin="record-data" source="wos-lite">antipsychotic drug</api:keyword><api:keyword origin="record-data" source="wos-lite">clozapine</api:keyword><api:keyword origin="record-data" source="wos-lite">quetiapine</api:keyword><api:keyword origin="record-data" source="wos">5-HT1A receptor</api:keyword><api:keyword origin="record-data" source="wos">GTP gamma[S-35]</api:keyword><api:keyword origin="record-data" source="wos">brain, human</api:keyword><api:keyword origin="record-data" source="wos">antipsychotic drug</api:keyword><api:keyword origin="record-data" source="wos">clozapine</api:keyword><api:keyword origin="record-data" source="wos">quetiapine</api:keyword><api:keyword origin="record-data" source="wos">GAMMA-S BINDING</api:keyword><api:keyword scheme="for" origin="issn-inferred">0801 Artificial Intelligence and Image Processing</api:keyword><api:keyword scheme="for" origin="issn-inferred">1115 Pharmacology and Pharmaceutical Sciences</api:keyword><api:keyword scheme="for" origin="issn-inferred">1701 Psychology</api:keyword><api:keyword scheme="for" origin="issn-inferred">1702 Cognitive Sciences</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Behavioral Science &amp; Comparative Psychology</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Pharmacology &amp; Pharmacy</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3109 Zoology</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3214 Pharmacology and pharmaceutical sciences</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">5204 Cognitive and computational psychology</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">5205 Social and personality psychology</api:keyword></api:keywords></api:all-labels><api:journal issn="0014-2999" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/968259" title="European Journal of Pharmacology"><api:records><api:record source-name="summary"><api:title>European Journal of Pharmacology</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/694/relationships"/></api:object></api:result></api:response>